Read about the nine NVIDIA Inception partners named winners or finalists at the UCSF Health Awards.
Nine NVIDIA Inception partners were named winners or finalists at the UCSF Health Awards—a competition widely viewed as the Oscars of healthcare. With a standard for recognizing excellence and innovation, the awards are given across 13 digital health and five life sciences categories.
The event brings together the biopharma, hospital systems, providers, payors, patient networks, government officials, VCs, incubators, accelerators, innovators, and innovation centers in the US. The three-round competition lasts for 5 months, with more 400 judges evaluating over 1000 submissions.
Healthcare and life science (HCLS) demands new computing paradigms to meet the need for personalized medicine, next-generation clinics, enhanced quality of care, and breakthroughs in biomedical research to treat disease. With NVIDIA, HCLS companies can harness the power of AI and HPC to define the future of medicine and science.
This commitment is shown through investments in supercomputing, application framework development, and community support. The $100M investment NVIDIA made in Cambridge-1, the UK’s powerful supercomputer, is now open to select local startups to leverage.
The application framework, NVIDIA Clara Discovery, is built for developers to accelerate computational drug discovery. NVIDIA also sponsored the New Life Science Tool award, which recognizes the best emerging synthetic biology or AI-enabled drug development platform that is advancing the field of biotechnology.
BigHat Bioscience, a novel protein therapeutics company, was the winner for this category. BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Their AI-enabled experimental platform, powered by NVIDIA GPUs, integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of treatments for patients suffering from today’s most challenging diseases.
Two notable winners
- Aidoc, a leading provider of AI for medical imaging solutions, optimized on NVIDIA GPUs, deployed their solutions to over 600 medical centers and recently won the UCSF New Health Application of AI award. Aidoc will also be part of a panel at NVIDIA GTC on Nov. 9, at 7 am PT. Add it to your schedule >>
- Day Zero Diagnostics develops rapid, whole genome sequencing-based diagnostics on NVIDIA GPUs to modernize infectious disease diagnosis and treatment. They won the New Life Sciences Diagnostic award. Day Zero Diagnostics also recently won the 2021 Disruptive Technology award from The American Association for Clinical Chemistry.
- HeartFlow, the leader in AI powered precision heart care, optimized on NVIDIA GPUs, has deployed its solutions across 450+ hospitals and made finalists for New Health Application of AI award. Heartflow will be part of a GTC panel on Nov. 10, at 8 am PT. Add it to your schedule >>
- Sight Diagnostics, an AI powered blood diagnostic company, powered by NVIDIA GPUs, was a finalist for the New Health Application of AI award.
- 1upHealth, a serverless cloud-based healthcare API platform that simplifies connectivity, integration, and automation, with machine learning powered by NVIDIA GPUs, won the New EHR Advance category.
- Docbot, an AI powered gastrointestinal disease platform, was a finalist for new Life Sciences Diagnostic award.
- Biometrex Genetics, an AI powered drug development company, powered by NVIDIA GPUs, was a finalist for New Life Sciences Tool award.
“AI in healthcare is a new imperative,” said Mark H Goldstein, Founder and Chairman UCSF Health Hub. “Without smart algorithms and AI, digital health tools, and diagnostics can not hit velocity and impact healthcare the positive way many of us envision.”
Join our next webinar with UCSF Health to learn more about how to accelerate your AI in HCLS business with NVIDIA Inception.